125 related articles for article (PubMed ID: 26984774)
1. Expression of ATP6V1C1 during oral carcinogenesis.
Oliveira Alves MG; Carta CF; Padín-Iruegas ME; Pérez-Sayáns M; Suarez-Peñaranda JM; Issa JS; García-García A; Almeida JD
Biotech Histochem; 2016; 91(4):263-8. PubMed ID: 26984774
[TBL] [Abstract][Full Text] [Related]
2. Measurement of ATP6V1C1 expression in brush cytology samples as a diagnostic and prognostic marker in oral squamous cell carcinoma.
Pérez-Sayáns M; Reboiras-López MD; Somoza-Martín JM; Barros-Angueira F; Diz PG; Rey JM; García-García A
Cancer Biol Ther; 2010 Jun; 9(12):1057-64. PubMed ID: 20404513
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of C1 subunit of V-ATPase (ATPase C1) in oral squamous cell cancer and normal oral mucosa.
García-García A; Pérez-Sayáns M; Rodríguez MJ; Antúnez-López J; Barros-Angueira F; Somoza-Martín M; Gándara-Rey JM; Aguirre-Urízar JM
Biotech Histochem; 2012 Feb; 87(2):133-9. PubMed ID: 21526910
[TBL] [Abstract][Full Text] [Related]
4. Intracellular pH regulation in oral squamous cell carcinoma is mediated by increased V-ATPase activity via over-expression of the ATP6V1C1 gene.
Otero-Rey EM; Somoza-Martín M; Barros-Angueira F; García-García A
Oral Oncol; 2008 Feb; 44(2):193-9. PubMed ID: 17467328
[TBL] [Abstract][Full Text] [Related]
5. Similar Squamous Cell Carcinoma Epithelium microRNA Expression in Never Smokers and Ever Smokers.
Kolokythas A; Zhou Y; Schwartz JL; Adami GR
PLoS One; 2015; 10(11):e0141695. PubMed ID: 26544609
[TBL] [Abstract][Full Text] [Related]
6. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
[TBL] [Abstract][Full Text] [Related]
7. Expression of cell cycle markers and human papillomavirus infection in oral squamous cell carcinoma: use of fuzzy neural networks.
Lo Muzio L; D'Angelo M; Procaccini M; Bambini F; Calvino F; Florena AM; Franco V; Giovannelli L; Ammatuna P; Campisi G
Int J Cancer; 2005 Jul; 115(5):717-23. PubMed ID: 15729691
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of amyloid precursor protein in oral squamous cell carcinoma.
Ko SY; Lin SC; Chang KW; Wong YK; Liu CJ; Chi CW; Liu TY
Int J Cancer; 2004 Sep; 111(5):727-32. PubMed ID: 15252842
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
[TBL] [Abstract][Full Text] [Related]
10. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
11. Silencing of atp6v1c1 prevents breast cancer growth and bone metastasis.
Feng S; Zhu G; McConnell M; Deng L; Zhao Q; Wu M; Zhou Q; Wang J; Qi J; Li YP; Chen W
Int J Biol Sci; 2013; 9(8):853-62. PubMed ID: 24155661
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 receptor antagonist (IL1RN) is associated with suppression of early carcinogenic events in human oral malignancies.
Shiiba M; Saito K; Yamagami H; Nakashima D; Higo M; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Takiguchi Y; Tanzawa H
Int J Oncol; 2015 May; 46(5):1978-84. PubMed ID: 25738940
[TBL] [Abstract][Full Text] [Related]
13. [Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].
Lu XZ; Yin XM; Feng YY; Duan LQ; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1165-7. PubMed ID: 18676253
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of TLR4 and TLR9 in various grades of oral epithelial dysplasia and squamous cell carcinoma, and their roles in tumor progression: a pilot study.
Kotrashetti VS; Nayak R; Bhat K; Hosmani J; Somannavar P
Biotech Histochem; 2013 Aug; 88(6):311-22. PubMed ID: 23651260
[TBL] [Abstract][Full Text] [Related]
15. Abnormal expression of PI3K isoforms in patients with tobacco-related oral squamous cell carcinoma.
Garg R; Kapoor V; Mittal M; Singh MK; Shukla NK; Das SN
Clin Chim Acta; 2013 Feb; 416():100-6. PubMed ID: 23228846
[TBL] [Abstract][Full Text] [Related]
16. Low/negative expression of DDX3 might predict poor prognosis in non-smoker patients with oral cancer.
Lee CH; Lin SH; Yang SF; Yang SM; Chen MK; Lee H; Ko JL; Chen CJ; Yeh KT
Oral Dis; 2014 Jan; 20(1):76-83. PubMed ID: 23410059
[TBL] [Abstract][Full Text] [Related]
17. Increased EMMPRIN (CD 147) expression during oral carcinogenesis.
Vigneswaran N; Beckers S; Waigel S; Mensah J; Wu J; Mo J; Fleisher KE; Bouquot J; Sacks PG; Zacharias W
Exp Mol Pathol; 2006 Apr; 80(2):147-59. PubMed ID: 16310185
[TBL] [Abstract][Full Text] [Related]
18. S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma.
Sapkota D; Bruland O; Parajuli H; Osman TA; Teh MT; Johannessen AC; Costea DE
BMC Cancer; 2015 Sep; 15():631. PubMed ID: 26353754
[TBL] [Abstract][Full Text] [Related]
19. Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.
McConnell M; Feng S; Chen W; Zhu G; Shen D; Ponnazhagan S; Deng L; Li YP
Oncotarget; 2017 Jul; 8(29):47675-47690. PubMed ID: 28504970
[TBL] [Abstract][Full Text] [Related]
20. The use of tissue microarrays for semiquantitative evaluation of ATPaseC1 expression is ineffective.
Pérez-Sayáns M; Suárez-Peñaranda JM; Aguirre-Urízar JM; Rodríguez-Tojo MJ; Barros-Angueira F; Gallas-Torreira M; García-García A
Biotech Histochem; 2015; 90(6):439-44. PubMed ID: 25901422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
